dostarlimab
gsk
['5593', 'dostarlimab']
comparing survival outcomes between endometrial cancer patients receiving anti-pd-1 antibody dostarlimab in a single-arm trial and an equivalent real-world external control arm is the focus of abstract # 5593. #asco2022 
Global provider of Outsourced Clinical Research